相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
Aye Aye Thike et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer
Julia J. Gorski et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
Gemma Molyneux et al.
CELL STEM CELL (2010)
Does Tumor Size Trump Biology?
Sunil Badve
CLINICAL BREAST CANCER (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas)
Caterina Marchio et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
Aye Aye Thike et al.
MODERN PATHOLOGY (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Britta Weigelt et al.
LANCET ONCOLOGY (2010)
Tumor size and survival in breast cancer-a reappraisal
William D. Foulkes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Molecular Evidence for Progression of Microglandular Adenosis (MGA) to Invasive Carcinoma
Sandra J. Shin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Most Basal-like Breast Carcinomas Demonstrate the Same Rb-/p16+Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
Andrea Proctor Subhawong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Insight into microRNA regulation by analyzing the characteristics of their targets in humans
Zihua Hu
BMC GENOMICS (2009)
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
Britta Weigelt et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Patho-biological aspects of basal-like breast cancer
Emad A. Rakha et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Dae-Seop Shin et al.
CANCER RESEARCH (2009)
Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma
Felipe C. Geyer et al.
HISTOPATHOLOGY (2009)
Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?
Felipe Correa Geyer et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
Marick Lae et al.
MODERN PATHOLOGY (2009)
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim et al.
NATURE MEDICINE (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The role of molecular analysis in breast cancer
Felipe C. Geyer et al.
PATHOLOGY (2009)
Triple-negative/basal-like breast cancer: review
Emad A. Rakha et al.
PATHOLOGY (2009)
CT-X antigen expression in human breast cancer
Anita Grigoriadis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Do 'basal-like' breast cancers really exist?
Barry Gusterson
NATURE REVIEWS CANCER (2009)
CK5 Is More Sensitive Than CK5/6 in Identifying the Basal-like Phenotype of Breast Carcinoma
Rohit Bhargava et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma
Ibrahim M. Khalifeh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
αB-crystallin:: A novel marker of invasive basal-like and metaplastic breast carcinomas
Stephanie M. Sitterding et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2008)
Platinum-based chemotherapy in triple-negative breast cancer
B. Sirohi et al.
ANNALS OF ONCOLOGY (2008)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Alfonso Sanchez-Munoz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Are triple-negative and basal-like breast cancer synonymous?
Emad Rakha et al.
CLINICAL CANCER RESEARCH (2008)
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast
Anne Vincent-Salomon et al.
CLINICAL CANCER RESEARCH (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
Is acinic cell carcinoma a variant of secretory carcinoma?: A FISH study using ETV6 'split apart' probes
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
Oluwole Fadare et al.
HUMAN PATHOLOGY (2008)
How basal are triple-negative breast cancers?
Francois Bertucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nestin is expressed in basal-like and triple negative breast cancers
S. Parry et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Refinement of breast cancer classification by molecular characterization of histological special types
B. Weigelt et al.
JOURNAL OF PATHOLOGY (2008)
Breast cancer special types: why bother?
J. S. Reis-Filho et al.
JOURNAL OF PATHOLOGY (2008)
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy
Judith A. Gilbert et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The beginning of the end for microarrays?
Jay Shendure
NATURE METHODS (2008)
Impact of basal-like breast carcinoma determination for a more specific therapy
Ernad A. Rakha et al.
PATHOBIOLOGY (2008)
CD109 expression in basal-like breast carcinoma
Masaki Hasegawa et al.
PATHOLOGY INTERNATIONAL (2008)
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes
L. Melchor et al.
ONCOGENE (2008)
Immunohistochemical categorisation of ductal carcinoma in situ of the breast
P. Meijnen et al.
BRITISH JOURNAL OF CANCER (2008)
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
Kay Savage et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH (2008)
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Andrew E. Teschendorff et al.
BREAST CANCER RESEARCH (2008)
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Fabien Reyal et al.
BREAST CANCER RESEARCH (2008)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
Bhumsuk Keam et al.
BMC CANCER (2007)
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and def ines basal-like breast tumors
Mona L. Gauthier et al.
CANCER CELL (2007)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells
Masaki Hasegawa et al.
PATHOLOGY INTERNATIONAL (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
Joana Paredes et al.
VIRCHOWS ARCHIV (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Potential chemotherapy options in the triple negative subtype of breast cancer
Kadri Altundag et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
Anne Vincent-Salomon et al.
BREAST CANCER RESEARCH (2007)
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2007)
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
Mervi Jumppanen et al.
BREAST CANCER RESEARCH (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike et al.
BREAST CANCER RESEARCH (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
Basal-like breast cancer and the BRCA1 phenotype
N. C. Turner et al.
ONCOGENE (2006)
Molecular classification of breast cancer: Limitations and potential
Lajos Pusztai et al.
ONCOLOGIST (2006)
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
Socorro Maria Rodriguez Pinilla et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J. S. Reis et al.
JOURNAL OF PATHOLOGY (2006)
Metaplastic breast carcinomas are basal-like tumours
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2006)
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas:: an immunohistochemical and chromogenic in situ hybridisation analysis
Jorge S. Reis-Filho et al.
MODERN PATHOLOGY (2006)
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
S. Banerjee et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast
L. G. Fulford et al.
HISTOPATHOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Ductal carcinoma in situ with basal-like phenotype:: a possible precursor to invasive basal-like breast cancer
BB Bryan et al.
MODERN PATHOLOGY (2006)
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
Francois Bertucci et al.
CANCER RESEARCH (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
Molecular alterations in columnar cell lesions of the breast
DJ Dabbs et al.
MODERN PATHOLOGY (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
alpha B-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
JV Moyano et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Classification of ductal carcinoma in situ by gene expression profiling
Juliane Hannemann et al.
BREAST CANCER RESEARCH (2006)
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Lyndsay N. Harris et al.
BREAST CANCER RESEARCH (2006)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza et al.
BREAST CANCER RESEARCH (2006)
Typical medullary breast carcinomas have a basal/myoepithelial phenotype
J Jacquemier et al.
JOURNAL OF PATHOLOGY (2005)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Targeting the DNA repair defect of BRCA tumours
N Turner et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer
JB Arnes et al.
CLINICAL CANCER RESEARCH (2005)
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
J Palacios et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes
C Jones et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Microglandular adenosis with transition into adenoid cystic carcinoma of the breast
A Geza et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Distinct genetic and epigenetic changes in medullary breast cancer
P Osin et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2003)
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis
PL Welcsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Absence of CCND 1 gene amplification in breast tumours of BRCA1 mutation carriers
SAJ Vaziri et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
C Beger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Carcinoma arising in microglandular adenosis: An immunohistochemical analysis of 20 intraepithelial and invasive neoplasms
C Koenig et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases
H Tsuda et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
